Eunsoo T. Kim

Busan, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

Melandryoside attenuates steatohepatitis and fibrosis by restoring PPM1A-mediated SMAD signaling termination.

Melandryoside attenuates steatohepatitis and fibrosis by restoring PPM1A-mediated SMAD signaling termination.

Journal: Frontiers in pharmacology

Published: May 13, 2026

Structure-Electrical Property Relationships of Spike-Structured Conductive Silicone Interfaces for Wearable Trigeminal Microcurrent Stimulation in Electroceutical Devices.

Structure-Electrical Property Relationships of Spike-Structured Conductive Silicone Interfaces for Wearable Trigeminal Microcurrent Stimulation in Electroceutical Devices.

Journal: Polymers

Published: April 30, 2026

Eosinophil-Epithelial Cell Crosstalk at Mucosal Barriers: From Homeostatic Regulation to Disease Pathogenesis.

Eosinophil-Epithelial Cell Crosstalk at Mucosal Barriers: From Homeostatic Regulation to Disease Pathogenesis.

Journal: Cells

Published: April 20, 2026

Mucosal Vaccine Development: From Adjuvant Design to Next-Generation Delivery Strategies.

Mucosal Vaccine Development: From Adjuvant Design to Next-Generation Delivery Strategies.

Journal: Biomedicines

Published: April 03, 2026

Simulation and Experimental Study of Moderate Electric Field (MEF) Effects on Inactivation of Listeria monocytogenes and Vibrio parahaemolyticus in Surimi Paste.

Simulation and Experimental Study of Moderate Electric Field (MEF) Effects on Inactivation of Listeria monocytogenes and Vibrio parahaemolyticus in Surimi Paste.

Journal: Foods (Basel, Switzerland)

Published: April 02, 2026

A randomized phase III clinical trial of weekly versus tri-weekly cisplatin-based chemoradiotherapy for locally advanced cervical cancer: results of the TACO (GCIG/KGOG 1027/THAI 2012) study.

A randomized phase III clinical trial of weekly versus tri-weekly cisplatin-based chemoradiotherapy for locally advanced cervical cancer: results of the TACO (GCIG/KGOG 1027/THAI 2012) study.

Journal: ESMO open

Published: November 18, 2025

Carbutamide, an Obsolete Anti-Diabetic Drug, Has Potential as a Potent Anticolitic Agent via Azo-Conjugation with Mesalazine.

Carbutamide, an Obsolete Anti-Diabetic Drug, Has Potential as a Potent Anticolitic Agent via Azo-Conjugation with Mesalazine.

Journal: Pharmaceutics

Published: September 19, 2025

Chronic PET-Microplastic Exposure: Disruption of Gut-Liver Homeostasis and Risk of Hepatic Steatosis.

Chronic PET-Microplastic Exposure: Disruption of Gut-Liver Homeostasis and Risk of Hepatic Steatosis.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: June 29, 2025

Clinical practice guidelines for the management of refractory postherpetic neuralgia by the Korean Pain Society.

Clinical practice guidelines for the management of refractory postherpetic neuralgia by the Korean Pain Society.

Journal: The Korean journal of pain

Published: May 12, 2025

Protective Effects of Xanthorrhizol-Rich Extracts Against PM-Induced Skin Damage in Human Keratinocytes and 3D-Reconstructed Skin Models.

Protective Effects of Xanthorrhizol-Rich Extracts Against PM-Induced Skin Damage in Human Keratinocytes and 3D-Reconstructed Skin Models.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: March 13, 2025

Effect of glucagon-like peptide-1 receptor agonist on paclitaxel induced neurotoxicity in dorsal root ganglion neuronal cells in vitro.

Effect of glucagon-like peptide-1 receptor agonist on paclitaxel induced neurotoxicity in dorsal root ganglion neuronal cells in vitro.

Journal: The Korean journal of pain

Published: December 23, 2024

Subcutaneous tunnelling versus conventional insertion of peripherally inserted central catheters in hospitalized patients (TUNNEL-PICC): a multi-centre, open-label, randomized, controlled trial.

Subcutaneous tunnelling versus conventional insertion of peripherally inserted central catheters in hospitalized patients (TUNNEL-PICC): a multi-centre, open-label, randomized, controlled trial.

Journal: The Journal of hospital infection

Published: June 25, 2024

Showing 1-12 of 53

Last Updated: 09/26/2026